KaloBios Pharmaceuticals files for bankruptcy in wake of Shkreli arrest

(Reuters) – KaloBios Pharmaceuticals Inc, a biotechnology company that fired Chief Executive Martin Shkreli earlier this month after his arrest on charges of securities fraud, filed for Chapter 11 bankruptcy on Tuesday.